March 22, 2018 -- CAMBRIDGE, Mass.--Rheos Medicines, Inc. was launched today with $60 million in Series A financing backed by Third Rock Ventures, LLC. Rheos is pioneering immunometabolism as a novel approach to tune metabolic pathways in immune cells to treat disease. The com...